We are AliveDx.
Products & Services
At AliveDx, we empower diagnostic insights,
transform patient care, and innovate for life.
With 30+ years in in-vitro diagnostics, we
advance global diagnostics in autoimmune,
allergy, and beyond. Our Alba, MosaiQ, and
LumiQ brands generate both economic and
clinical value by simplifying workflows and
delivering fast, accurate results that enhance
clinical decision-making. At AliveDx,
we innovate for life.
Driven to Provide Solutions
AliveDx’s ability to envision what’s possible in diagnostics is grounded in our 30-year heritage in immunohematology and driven by our longstanding passion for understanding and addressing customer needs.
MosaiQ®
Our MosaiQ solution is designed to shorten time-to-diagnosis for patients by providing faster in-vitro test results. As an easy-to-use single solution, the platform performs multiple tests and gives maximum flexibility to laboratorians and clinicians.
LumiQ
All-in-one Immunofluorescence (IFA) solution – the LumiQ system is designed to provide workflow efficiency from patient sample in, to result out
Alba
The Alba manual reagent product line is backed by expert technical support and reliable customer service. Join our satisfied customers and see the difference that Alba can make in your laboratory.
Ready to Innovate for Life?
Discover how our solutions help.
Trending Topics
Recent press, briefings and insights helping you stay informed on AliveDx news.
-
AliveDx Recertified to ISO 14001 Environmental Standard
We’re proud to announce that AliveDx has achieved recertification to ISO 14001, the international standard for Environmental Management Systems (EMS). This milestone demonstrates our ongoing commitment to reducing environmental impact, improving sustainability, and maintaining operational excellence. ISO 14001 is especially
-
AliveDx Earns Great Place To Work Certification™ in its 3 sites: Switzerland, UK and US
AliveDx is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at AliveDx. Great Place To Work® is the global authority on workplace culture, employee
-
AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L sign two strategic distribution agreements in Kuwait
AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L. have signed two strategic distribution agreements, which will enable Warba Medical Supplies to distribute the MosaiQ® and LumiQ® solutions in Kuwait. The distribution agreements take effect immediately. This partnership underscores AliveDx’s
-
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, have signed a distribution agreement, which will enable Bio-Strategy to distribute the LumiQ™ solution in Australia and New Zealand. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to
-
Join us at EuroMedLab 2025
We are excited to announce our participation in the upcoming EuroMedLab Congress in Brussels, Belgium, from 19-22 May 2025. Visit us at booth #245 to learn more about our MosaiQ® and LumiQ™ innovative, turnkey, fully automated autoimmune diagnostic solutions. The
-
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
Eysins, Switzerland, 3 April 2025 – Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ AiPlex CTDplus multiplex assay, which received
